. 2012 Apr 2;13(4):4268–4280. doi: 10.3390/ijms13044268

Table 2.

CARD15/NOD2 mutant allele frequencies in Saudi Crohn’s disease (CD) patients and controls.

	Homozygous wild-type	Homozygous mutant	P	Heterozygous mutant	P	Or (95% ci) mutant	Or (95% ci) hetero
Leu1007fsinsC
Patients	7 (15.2%)	3 (6.5%)	0.012 ^*	36 (78.3%)	<0.0001 ^*	5.29 (2.71–10.29)	7.71 (2.87–20.71)
Controls	30 (60.0%)	0 (0.0%)		20 (20.0%)	<0.0001 ^*	5.29 (2.71–10.29)	7.71 (2.87–20.71)
Arg702Trp
Patients	8 (17.4%)	10 (21.7%)	<0.0001 ^*	28 (60.6%)	<0.0001 ^*	21.87 (3.99–119.9)	9.42 (3.43–25.9)
Controls	35 (70.0%)	2 (4.0%)		13 (26.0%)	<0.0001 ^*	21.87 (3.99–119.9)	9.42 (3.43–25.9)
Gly908Arg
Patients	5 (10.9%)	3 (6.5%)	0.015 ^*	38 (82.6%)	<0.0001 ^*	21.0 (1.81–243.2)	19.0 (6.20–58.21)
Controls	35 (70.0%)	1 (2.0%)		14 (28.0%)	<0.0001 ^*	21.0 (1.81–243.2)	19.0 (6.20–58.21)

Statistically significant at P ≤ 0.05.